Bayer wins MHRA approval for Kerendia in heart failure
New authorisation offers additional option for patients with lvef ≥40%

Read the full article on the original site.
Read Full ArticleNew authorisation offers additional option for patients with lvef ≥40%

Read the full article on the original site.
Read Full Article